Compare Globus Medical Inc. Class A Common Stock (GMED) vs iShares Global Clean Energy ETF (ICLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs iShares Global Clean Energy ETF — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while iShares Global Clean Energy ETF trades at $16.42 (market cap $2.21B). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 4.6× iShares Global Clean Energy ETF's market cap, and Globus Medical Inc. Class A Common Stock is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and iShares Global Clean Energy ETF for 88 Days on average.
| GMED | ICLN | |
|---|---|---|
Market Cap | $10.25B | $2.21B |
Volume | 1,108,124 | 6,641,356 |
Sector | Health | — |
52-Week High | $96.82 | $23.75 |
52-Week Low | $58.33 | $16.00 |
Typical Hold Time | 0 Days | 88 Days |
Enterprise Value | $9.76B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
ICLN is trading at $16.64, down 2.8% today amid bearish technical signals with 15 sell indicators versus 1 buy. The ETF faces headwinds from clean energy sector volatility, having experienced a 57.2% maximum drawdown historically. Recent news highlights competition from traditional energy ETFs delivering stronger returns with lower fees, though geopolitical tensions are accelerating global renewable energy adoption.
The outlook remains cautious due to high volatility and expense ratio disadvantages versus fossil fuel alternatives. Key risks include sector competition and regulatory uncertainty, while potential catalysts include increased global renewable investment and data center energy demand growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →
